DTIL Precision BioSciences, Inc.

Develops technology to produce custom, genome-editing enzymes for human health and biological research

$0.85  +0.02 (2.41%)
As of 03/21/2023 16:00:00 EST     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  03/27/2019
Outstanding shares:  110,958,955
Average volume:  385,817
Market cap:   $129,821,977
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BJ0M2S0

---

Valuation   (See tab for details)

---

PE ratio:   0.00
PB ratio:   0.00
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%